Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Notes Payables: 2022-2023

Historic Notes Payables for ADC Therapeutics (ADCT) over the last 1 years, with Sep 2023 value amounting to $14.3 million.

  • ADC Therapeutics' Notes Payables rose 14.92% to $14.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $14.3 million, marking a year-over-year increase of 14.92%. This contributed to the annual value of $12.5 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Notes Payables is $14.3 million, which was up 3.38% from $13.9 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Notes Payables ranged from a high of $14.3 million in Q3 2023 and a low of $12.5 million during Q3 2022.
  • Its 2-year average for Notes Payables is $13.3 million, with a median of $13.5 million in 2023.
  • Data for ADC Therapeutics' Notes Payables shows a peak YoY increased of 14.92% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows ADC Therapeutics' Notes Payables stood at $12.5 million in 2022, then increased by 14.92% to $14.3 million in 2023.
  • Its Notes Payables stands at $14.3 million for Q3 2023, versus $13.9 million for Q2 2023 and $13.5 million for Q1 2023.